Azelastine Hydrochloride Spray, Metered
Product Images NDC 69168-478

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Azelastine Hydrochloride (NDC 69168-478). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Allegiant Health, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Azelastine Hydrochloride Label (478 Nasal Spray Azelastine Hydrochloride 1)

Azelastine Hydrochloride Label (478   Nasal Spray Azelastine Hydrochloride 1)
This is a description of an antihistamine nasal spray product containing Azelastine Hydrochloride. The spray is intended for use in the nose only, and should not be sprayed in the eyes or mouth. It warns about the possibility of drowsiness which may be increased when using alcohol, sedatives, or tranquilizers. Instructions include avoiding alcoholic drinks and being cautious when driving or operating machinery. The product should be stored between 20°C to 25°C (68°F to 77°F), and kept out of reach of children. The manufacturer is Allgiant Health in Canada, and the product has 120 metered sprays. For questions or comments, a contact number is provided.*
FDA Label Image

Azelastine Hydrochloride Carton (478 Nasal Spray Azelastine Hydrochloride 2)

Azelastine Hydrochloride Carton (478   Nasal Spray Azelastine Hydrochloride 2)
This is a description of HealthA2Z® Allergy Relief Nasal Spray. The spray provides up to 24-hour relief from nasal congestion, runny nose, sneezing, and itchy nose. It contains Azelastine Hydrochloride as the active ingredient. The product is free from steroids, alcohol, and fragrance. The nasal spray is suitable for adults and children aged 12 years and older, with specific dosage instructions provided. It is important to store the spray between 20°C to 25°C and not use it if the package is damaged. The product is intended for temporary relief of hay fever or other upper respiratory allergies, but users are advised to consult a doctor in certain situations. A toll-free helpline is available for questions or comments. The nasal spray is manufactured for Allegiant Health in Canada and is compared to Astepro®.*
FDA Label Image

Azelastine Hydrochloride Insert (478 Nasal Spray Azelastine Hydrochloride 3)

Azelastine Hydrochloride Insert (478   Nasal Spray Azelastine Hydrochloride 3)
This is a user guide for Azelastine Hydrochloride Nasal Spray, providing detailed instructions on how to prime the bottle, use the spray, and clean a clogged nozzle. It includes information on when to prime the bottle and how to correctly administer the spray in your nostrils. The guide specifies dosage directions for adults and children aged 6 years and older, emphasizing the importance of not exceeding the recommended number of sprays per day. It also mentions safety precautions, such as not tilting your head back immediately after use to prevent the medicine from going into your throat. The guide reminds users that drowsiness may occur and advises avoiding alcoholic drinks while using the product.*
FDA Label Image

Azelastine Hydrochloride Insert (478 Nasal Spray Azelastine Hydrochloride 4)

Azelastine Hydrochloride Insert (478   Nasal Spray Azelastine Hydrochloride 4)
This text provides instructions on how to clean a clogged nozzle of azelastine hydrochloride nasal spray. It advises against using sharp objects to unclog the nozzle, recommends soaking the spray pump unit in warm water, and pumping the nozzle while holding it underwater to clear the clog. After cleaning, it suggests air-drying the pump unit before reattaching it to the bottle and priming it. For questions or comments, contact Allegiant Health.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.